Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types (1)
Select products & services
Select solutions
Active Filters (1)
Clear All
73 - 84 of 98 Results
Sort by:
Best Match

Exploring current and future approaches for targeting KRAS
Get the latest insights on KRAS and see how it has switched from being an undruggable to a druggable cancer target

Shifting the treatment paradigm: the promise of gene therapy for neurodegenerative diseases
Traditional treatments for neurodegenerative diseases focus on managing symptoms, but recent advancements in gene therapy offer hope for more effective and sustainable solutions. Read now!

Transforming cell therapies with dual CAR strategies
This white paper discusses the potential of dual CARs in transforming cell therapies.

Conditional knockout generation using targeted exon excision and synthetic introns
This white paper explores approaches for conditional knockout generation using targeted exon excision and synthetic introns.

Cell painting - a cellular imaging and machine learning approach to drug discovery
Cell painting solutions from Revvity offer powerful phenotypic high-content screening methods that help to accelerate drug discovery by delivering more predictive data.

Artificial intelligence, machine learning and deep learning: applications in cellular imaging for improved drug discovery productivity
Learn how Artificial Intelligence (AI), Machine Learning (ML) and Deep Learning (DL) are used in cellular imaging applications for improved drug discovery productivity in this white paper.

Phenotypic drug discovery with high content screening
High content screening, a powerful approach to phenotypic drug discovery that leverages the rich information available in the image-based screens.

Therapeutic targeting of the tumor microenvironment
Understanding How Tumor and Host Cells Interact to Support Tumor Development and Therapeutic Resistance

Huntington’s disease: progress and future perspectives
Insight into recent scientific breakthroughs and therapeutic approaches currently being pursued by the HD research community.

Establishing an automated high-throughput assay that supports the growth of prostate cancer organoids
Researchers concluded that their study demonstrates the ability to automate preclinical testing with prostate cancer organoids with diverse phenotypes.

Leveraging the microbiome to strengthen immune therapeutic response
Understanding the role bacteria play, whether it be oncogenesis, tumor promotion, or treatment effectiveness, may provide an opportunity for intervention at the microbiome level in favor of cancer regression.

High-throughput approaches to overcome antimicrobial resistance - part 1
The use of machine learning algorithms to predict how an organism is going to behave in response to an antimicrobial.


Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.